Literature DB >> 20191254

Non-pharmacologic management of sleep disturbance in Alzheimer's disease.

R David1, J Zeitzer, L Friedman, A Noda, R O'Hara, P Robert, J A Yesavage.   

Abstract

Sleep and wake in Alzheimer's disease (AD) are often fragmented as manifested by bouts of wakefulness at night and napping during the day. Management of sleep disturbances in AD is important because of their negative impact on both patients and caregivers. Pharmacological treatments, mainly sedative-hypnotics and antipsychotics, are often used but can be associated with significant adverse effects. Non-pharmacological treatments represent a beneficial alternative approach to the management of sleep disturbances in AD since they are associated with fewer adverse effects and their efficacy can be sustained after treatment has been completed. The aim of this article is to review non-pharmacological treatments, such as sleep hygiene, sleep restriction therapy (SRT), cognitive behavioral therapy (CBT), light therapy, and continuous positive airway pressure (CPAP), for the management of sleep/wake disturbances in AD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20191254     DOI: 10.1007/s12603-010-0050-9

Source DB:  PubMed          Journal:  J Nutr Health Aging        ISSN: 1279-7707            Impact factor:   4.075


  61 in total

1.  Illumination levels in nursing home patients: effects on sleep and activity rhythms.

Authors:  T Shochat; J Martin; M Marler; S Ancoli-Israel
Journal:  J Sleep Res       Date:  2000-12       Impact factor: 3.981

2.  Exposure to light in healthy elderly subjects and Alzheimer's patients.

Authors:  S S Campbell; D F Kripke; J C Gillin; J C Hrubovcak
Journal:  Physiol Behav       Date:  1988

3.  Sleep disorders and melatonin rhythms in elderly people.

Authors:  I Haimov; M Laudon; N Zisapel; M Souroujon; D Nof; A Shlitner; P Herer; O Tzischinsky; P Lavie
Journal:  BMJ       Date:  1994-07-16

4.  Sleep apnea in Alzheimer's dementia: correlation with mental deterioration.

Authors:  C F Reynolds; D J Kupfer; L S Taska; C C Hoch; D E Sewitch; K Restifo; D G Spiker; B Zimmer; R S Marin; J Nelson
Journal:  J Clin Psychiatry       Date:  1985-07       Impact factor: 4.384

5.  An actigraphic comparison of sleep restriction and sleep hygiene treatments for insomnia in older adults.

Authors:  L Friedman; K Benson; A Noda; V Zarcone; D A Wicks; K O'Connell; J O Brooks; D L Bliwise; J A Yesavage
Journal:  J Geriatr Psychiatry Neurol       Date:  2000       Impact factor: 2.680

6.  Effect of timed bright light treatment for rest-activity disruption in institutionalized patients with Alzheimer's disease.

Authors:  Glenna A Dowling; Judy Mastick; Erin M Hubbard; Jay S Luxenberg; Robert L Burr
Journal:  Int J Geriatr Psychiatry       Date:  2005-08       Impact factor: 3.485

7.  Psychotropic drugs and risk of recurrent falls in ambulatory nursing home residents.

Authors:  P B Thapa; P Gideon; R L Fought; W A Ray
Journal:  Am J Epidemiol       Date:  1995-07-15       Impact factor: 4.897

8.  A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease.

Authors:  Clifford Singer; Rochelle E Tractenberg; Jeffrey Kaye; Kim Schafer; Anthony Gamst; Michael Grundman; Ronald Thomas; Leon J Thal
Journal:  Sleep       Date:  2003-11-01       Impact factor: 5.849

9.  Continuous positive airway pressure deepens sleep in patients with Alzheimer's disease and obstructive sleep apnea.

Authors:  Jana R Cooke; Sonia Ancoli-Israel; Lianqi Liu; Jose S Loredo; Loki Natarajan; Barton S Palmer; Feng He; Jody Corey-Bloom
Journal:  Sleep Med       Date:  2009-08-20       Impact factor: 3.492

10.  Melatonin fails to improve sleep or agitation in double-blind randomized placebo-controlled trial of institutionalized patients with Alzheimer disease.

Authors:  Philip R Gehrman; Donald J Connor; Jennifer L Martin; Tamar Shochat; Jody Corey-Bloom; Sonia Ancoli-Israel
Journal:  Am J Geriatr Psychiatry       Date:  2009-02       Impact factor: 4.105

View more
  8 in total

1.  Circadian activity rhythms and risk of incident dementia and mild cognitive impairment in older women.

Authors:  Gregory J Tranah; Terri Blackwell; Katie L Stone; Sonia Ancoli-Israel; Misti L Paudel; Kristine E Ensrud; Jane A Cauley; Susan Redline; Teresa A Hillier; Steven R Cummings; Kristine Yaffe
Journal:  Ann Neurol       Date:  2011-11       Impact factor: 10.422

2.  Editorial: sleep and dementia.

Authors:  A Gabelle; Y Dauvilliers
Journal:  J Nutr Health Aging       Date:  2010-03       Impact factor: 4.075

3.  Editorial: can we improve care for patients with dementia?

Authors:  J E Morley
Journal:  J Nutr Health Aging       Date:  2011-08       Impact factor: 4.075

4.  Neuropsychiatric symptoms in Alzheimer's disease.

Authors:  Constantine G Lyketsos; Maria C Carrillo; J Michael Ryan; Ara S Khachaturian; Paula Trzepacz; Joan Amatniek; Jesse Cedarbaum; Robert Brashear; David S Miller
Journal:  Alzheimers Dement       Date:  2011-09       Impact factor: 21.566

5.  Behavioral management in the person with dementia.

Authors:  J E Morley
Journal:  J Nutr Health Aging       Date:  2013-01       Impact factor: 4.075

Review 6.  Pharmacotherapies for sleep disturbances in dementia.

Authors:  Jenny McCleery; Daniel A Cohen; Ann L Sharpley
Journal:  Cochrane Database Syst Rev       Date:  2016-11-16

Review 7.  Burden of Insomnia and Sleep Disturbances and the Impact of Sleep Treatments in Patients with Probable or Possible Alzheimer's Disease: A Structured Literature Review.

Authors:  Ruth Benca; W Joseph Herring; Rezaul Khandker; Zaina P Qureshi
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

8.  Effects of resveratrol on daily rhythms of locomotor activity and body temperature in young and aged grey mouse lemurs.

Authors:  Fabien Pifferi; Alexandre Dal-Pan; Solène Languille; Fabienne Aujard
Journal:  Oxid Med Cell Longev       Date:  2013-07-25       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.